Location preference

Enter your country so we can show you products that are available for you.

About Us

Unlocking the potential of blood- and cell-based therapies

Unlocking the potential of blood

As a global leader in blood component, therapeutic apheresis, and cellular technologies, we believe in the potential of blood to do even more for patients than it does today.

This belief inspires our innovation and strengthens our collaboration with customers.

Advancing healthcare worldwide

Working together with our customers, Terumo Blood and Cell Technologies can make safer, higher-quality transfusions available to more people. We can bring even more treatment options to patients through advanced blood therapies. And we can make the dream of new, cutting-edge blood and cell therapies the new standard of care. Our work has the potential to fundamentally improve healthcare.

We are guided by our customers' needs, aspirations, and ongoing drive to improve efficiency and patient outcomes.


We are a Terumo Group company

Terumo Group was founded in 1921 by a group of medical scientists led by Dr. Shibasaburo Kitasato, for the purpose of manufacturing reliable clinical thermometers in Japan.

For over a century, Terumo has been Contributing to Society through Healthcare. Today, Terumo Group’s extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, to blood transfusion and cell therapy technology, to medical products essential for daily clinical practice — such as transfusion systems, diabetes care, and peritoneal dialysis treatments.

Based in Tokyo and operating globally, Terumo employs more than 30,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions.

Terumo will further strive to be of value to patients, medical professionals, and society at large.


Featured resources

For operator's manuals and Instructions for Use, visit our eIFU website: Terumo.eifu.com. For more information, visit Help.TerumoBCT.com.

On-Demand Webinar

60 mins

Achieving Consistency in Fill and Finish for Cell Therapies

Researchers from Charles River Laboratories discuss efficiency in cell therapy manufacturing final formulation and how to reduce hands-on risk to therapy integrity

2 pg

Ethylene Oxide and Sterilization in Healthcare

Learn about medical device sterilization, the use of ethylene oxide, and the role they play in protecting public health

Video

3 mins

Mirasol Mode of Action: Advancing Global Blood Safety

See how Mirasol works to safely and effectively reduce pathogens and inactivate white blood cells

Video

2 mins

Our purpose: Unlocking potential

We see potential at every turn — new therapies, solutions that impact lives, and more

Success Story

6 mins

Reveos Customer Testimonial Video

Hear from Dr. Manuela Lopes from São João Hospital Center in Porto, Portugal, on how Reveos helped the center optimize blood processing operations

 

4 pg

TPE Technology Overview

Review this comparison of centrifugal and membrane therapeutic plasma exchange, including procedure times, blood flow rates, benefits, and more.

12 pg

T-ACE II+/TOMEs Total System

See how adding powerful software can yield better data management and more

Video

1 mins

Terumo Group Corporate Video

Learn about Terumo Group’s goal of advancing healthcare and enhancing patients’ quality of life

1 pg

Therapeutic Apheresis Contact Form

Ask for assistance finding an apheresis center that uses the Spectra Optia system or simply get in touch with our experts

1 pg

TOMEs + TSCD-II: Support Both Blood Product Safety and High Productivity

See the benefits of bidirectional connectivity when you integrate TSCD-II with TOMEs 

Product Information

2 mins

TSCD-II Sterile Tubing Welder Video

See TSCD-II in action and learn about the benefits

Product Information

1 mins

TSCD-Q: How It Works

See how the TSCD™-Q Sterile Tubing Welder creates simple, consistent, dependable polyurethane-specific tubing connections

Have questions or want to schedule a consultation to learn more about Terumo Blood and Cell Technologies?

To top